Table 3.
Clinicopathological features | Patients (n = 30) | hsa_circ_0000467 expressiona | P value | |
---|---|---|---|---|
High group | Low group | |||
Gender | 0.6903 | |||
Male | 21 | 10 (33.3%) | 11 (36.7%) | |
Female | 9 | 5 (16.7%) | 4 (13.3%) | |
Age (year) | 0.6660 | |||
≥70 | 7 | 4 (13.3%) | 3 (10.0%) | |
<70 | 23 | 11 (36.7%) | 12 (40.0%) | |
Tumor size (cm) | 0.7125 | |||
≥5 | 13 | 7 (23.3%) | 6 (20.0%) | |
<5 | 7 | 8 (26.7%) | 9 (30.0%) | |
Histological grade | 0.0224∗ | |||
Well | 3 | 0 (0.0%) | 3 (10.0%) | |
Moderately | 12 | 4 (13.3%) | 8 (26.7%) | |
Poor | 15 | 11 (36.7%) | 4 (13.3%) | |
TNM stage | 0.1953 | |||
I and II | 7 | 2 (6.7%) | 5 (16.7%) | |
III and IV | 23 | 13 (43.3%) | 10 (33.3%) | |
Pathological T category | 0.0674 | |||
T1 | 0 | 0 (0.0%) | 0 (0.0%) | |
T2 | 1 | 0 (0.0%) | 1 (3.3%) | |
T3 | 24 | 10 (33.3%) | 14 (46.7%) | |
T4 | 5 | 4 (13.3%) | 1 (3.3%) | |
Lymphatic node metastasis | 0.9720 | |||
N0 | 7 | 3 (10.0%) | 4 (13.3%) | |
N1 | 2 | 1 (3.3%) | 1 (3.3%) | |
N2 | 11 | 6 (20.0%) | 5 (16.7%) | |
N3 | 10 | 5 (16.7%) | 5 (16.7%) |
TNM: tumor node metastasis. Significant difference: ∗P < 0.05. aUsing median hsa_circ_0000467 values as cutoff.